Botanical

Persian Juniper

Juniperus excelsa

Persian Juniper (Juniperus excelsa) is an evergreen conifer native to the Middle East and Southwest Asia, known in Traditional Persian Medicine as Urs or Abhol. Its leaf extract has been used for centuries as a wound remedy and is now supported by a randomized clinical trial as a topical adjuvant for cutaneous leishmaniasis, a parasitic skin infection.

How it's used

Parts and preparations, and the conditions they're used for.

leaf · 5% hydroalcoholic extract topical creamCutaneous Leishmaniasis

These uses are flagged for review — traditional-use claims kept as reported, never as advice.

What the studies found

Findings backed by a source paper, not traditional use alone.

leaf · 5% hydroalcoholic extract topical cream — Complete cure in 82% vs 34% with placebo+cryotherapy (P<0.001); faster healing (6.48 vs 8.72 weeks, P=0.04) and fewer cryotherapy sessions needed (3.85 vs 6.54, P=0.026); no relapse at 6-month follow-up.

Read the source study →

Studies about Persian Juniper

1 completed study · newest first

Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial.

Mohammad Mahdi Parvizi et al. (2017) · PLoS neglected tropical diseases

This triple-blind randomized controlled trial with 62 completing patients tested whether a cream made from Persian Juniper (Juniperus excelsa) leaf extract could improve treatment of cutaneous leishmaniasis (CL), a sand-fly-transmitted skin infection that causes slow-healing ulcers. Traditional Persian Medicine has described this exact condition for centuries, calling it "Rish-e-Balkhi" (Balkh sore), and prescribed Juniperus excelsa — known locally as Urs or Abhol — for infected, non-healing wounds long before modern medicine identified the parasite responsible. Researchers in Shiraz, Iran enrolled 72 adults with confirmed leishmania skin lesions and randomly assigned them to apply either a 5% Juniperus excelsa extract cream or a matching placebo cream three times a day, both combined with standard weekly freezing (cryotherapy) treatments, for up to 12 weeks. Lesions were measured weekly from photographs, and everyone was checked again 6 months later for any sign the infection had come back. The results were striking: 82% of patients using the Juniperus cream were completely cured, compared to just 34% on placebo — a difference far too large to be chance (p<0.001). The herbal-cream group also healed faster (about 6.5 weeks versus 8.7 weeks) and needed fewer freezing sessions to get there. Statistically, patients using the cream were about 13.5 times more likely to achieve a complete cure. None of the cured patients in either group saw their infection return over the following six months. Side effects were mild — about 15% of the cream group had temporary redness and itching after roughly five weeks, similar to rates in the placebo group, and only one person stopped using it (after already being cured). This traditional remedy, still cheap and easy to prepare today, appears to meaningfully boost cure rates and speed healing for cutaneous leishmaniasis when added to standard cryotherapy. Because every patient in the study also received cryotherapy, the cream's effect on its own — without freezing treatment — is still untested, and the trial excluded facial lesions and children. Larger studies, including one testing the cream by itself, would help confirm exactly how much of the benefit comes from the herb.

Read summary →Full text available